Chemical Business Newsbase articles from April 2011

Chemical Business Newsbase archives from April 2011

New and generic drug approvals: Desloratadine and Pseudoephedrine Sulfate Extended Release Oral Tablet, Dr Reddy's Labs.
April 26, 2011... On 26 Apr 2011, the US Food and Drug Administration announced approval of ANDA 078366 for Desloratadine and Pseudoephedrine Sulfate Extended Release Oral Tablet. The product contains desloratadine at 5mg and pseudoephedrine sulfate at 240mg, is...

Valent BioSciences Corp announces plan to construct fermentation manufacturing facility in Osage, Iowa.
April 26, 2011... On 26 Apr 2011, Valent BioSciences Corp (VBC) announced that it will construct a new state-of-the-art fermentation manufacturing facility in Osage, Iowa, for the production of biorational agricultural, horticultural, public health and forestry...

Celanese Corp announces 20 % dividend increase; increases share repurchase plan.
April 25, 2011... On 25 Apr 2011, Celanese Corp announced that its board of directors has approved a 20 % increase in the company's quarterly common stock cash dividend. The dividend rate increased from $0.05 to $0.06 per share of common stock on a quarterly...

Wockhardt receives US FDA approval for generic version of Aricept tablets.
April 25, 2011... Wockhardt has received tentative approval from the US Food & Drug Administration (US FDA) for marketing 5mg and 10mg tablets of donepezil HCl, which is used for treatment of Alzheimer's disease and dementia. Donepezil is the generic name for...

Dr Reddy's reaches deal with Pfizer arm on patent case.
April 24, 2011... Dr Reddy's Laboratories Ltd (Dr Reddy's) has reached a settlement with Wyeth LLC, a 100% subsidiary of Pfizer, in New Jersey Federal Court on the issue of Dr Reddy's generic version of Wyeth's Effexor XR infringing the patent. The patent for...

Glencore omits Xstrata from listing prospectus.
April 24, 2011... The prospectus for the $60 bn London flotation of Glencore will not detail its ambition to take over FTSE-100 miner Xstrata, in effect ruling out the megadeal anytime soon. The Swiss commodities trader owns 34% of Xstrata and Glencore's chief...

Investors look for Russian update from BP.
April 24, 2011... Oil giants BP and Shell will announce 1Q 2011 results during the week beginning 25 Apr 2011. Analysts at Charles Stanley forecast that BP's earnings will be $5.7 bn (GBP 3.5 bn), marginally up on last year.

Tobacco firms used diet-aid chemicals.
April 24, 2011... British and American tobacco companies deliberately added powerful appetite-suppressing chemicals to cigarettes to attract people worried about their weight, according to internal industry documents dating from 1949 to 1999. Chemical additives...

Plastic, heal thyself: scientists invent smart polymers.
April 24, 2011... Scientists on Thu 21 Apr 2011 unveiled a new kind of plastic that can repair itself when exposed to ordinary light. The miracle material could extend the lifetime and improve the durability of dozens of polymer-based products, ranging from...

Japanese firm creates ultra-thin touchscreen glass substrate.
April 24, 2011... Gadgets of the future will benefit from touchscreens with the world's thinnest glass substrate, devised by Tokyo-based Asahi Glass Co. The thinnest commercial substrate on the market today is 0.3 mm thick, but the new soda-lime AGC-Asahi Glass...

Rhodia strengthens its innovation potential by taking an equity interest in Phoenix Venture Partners.(Company overview)
April 24, 2011... Specialty chemical producer Rhodia has acquired an equity interest in Phoenix Venture Partners LP, an investment fund focused on the financing and development of innovative technology start-up companies. This fund targets companies working...

Wacker Polymers to raise prices for dispersions in Europe.
April 24, 2011... WACKER POLYMERS is to raise its prices in Europe for VINNAPAS and VINNOL vinylacetate and acrylate based dispersions. Effective 15 Apr 2011, prices for vinylacetate and acrylate based dispersions will be increased by up to EUR 80/tonne, or as...

Paradip refinery commissioning by Nov 2012, says IOC.
April 23, 2011... Indian Oil Corp (IOC) expects to commission its Rup 29,777 crore Paradip Refinery by Nov 2012. The refinery will be commissioned in phases from Mar 2012 and will be completed by Nov 2012. (1 crore=10 M, 1 lakh=100,000).

New and generic drug approvals: Duexis Oral Tablet, Horizon Pharma.
April 23, 2011... On 23 Apr 2011, the US Food and Drug Administration announced approval of NDA 022519 for Duexis Oral Tablet. The product contains ibuprofen at 800mg and famotidine at 26.6mg, is manufactured by Horizon Pharma, and is prescription only. There are...

WHO says artemisinin preferred as malaria treatment.
April 23, 2011... The World Health Organization has amended its recommendation for malaria treatment, saying that artemisinin is preferred to quinine in treating severe cases among children, a WHO official said Thu 21 Apr 2011. The recommendation promoting...

Abbott Japan and Eisai receive approval to market the pancreatic digestive enzyme replacement drug Lipacreon (pancrelipase) in Japan.
April 22, 2011... On 22 Apr 2011, Abbott Japan Co Ltd and Eisai Co Ltd announced that they have received approval to market the pancreatic enzyme replacement drug Lipacreon (pancrelipase) in Japan as a pancreatic digestive enzyme replacement in patients with...

Halaven receives approval in Japan for the treatment of inoperable and recurrent breast cancer.
April 22, 2011... On 22 Apr 2011, Eisai Co Ltd announced that it has received approval to market its novel anticancer Halaven Injection 1mg (eribulin mesylate) in Japan for the treatment of inoperable and recurrent breast cancer. Discovered and developed by...

Rio Tinto and Government of Guinea sign new agreement for Simandou iron ore project.
April 22, 2011... On 22 Apr 2011, Rio Tinto, its subsidiary Simfer SA (Simfer), and the Government of Guinea have today signed a Settlement Agreement in Conakry, Guinea, that secures Rio Tinto's mining title in Guinea and paves the way for first shipment of iron...

FDA approves the first vaccine to prevent meningococcal disease in infants and toddlers.
April 22, 2011... On 22 Apr 2011, the US Food and Drug Administration approved the use of Menactra in children as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra...

New and generic drug approvals: Children's Cetirizine Hydrochloride Allergy Oral Solution, Silarx.
April 22, 2011... On 22 Apr 2011, the US Food and Drug Administration announced approval of ANDA 091130 for Children's Cetirizine Hydrochloride Allergy Oral Solution. The product contains cetirizine hydrochloride at 5mg/5l, is manufactured by Silarx, and is an...

New and generic drug approvals: Naratriptan Oral Tablet, Apotex.
April 22, 2011... On 22 Apr 2011, the US Food and Drug Administration announced approval of ANDA 091373 for Naratriptan Oral Tablet. The product contains naratriptan at 1mg or 2.5mg (eq base), is manufactured by Apotex, and is prescription only. There are no...

Idera Pharmaceuticals delays initiation of Phase II clinical trial of IMO-2125 in treatment-naive HCV patients.
April 22, 2011... Idera Pharmaceuticals Inc announced that it has chosen to delay initiating its planned Phase II clinical trial of IMO-2125 based on preliminary data from a 26-week nonclinical toxicology study of IMO-2125 in rodents. The Phase II clinical trial...

Genta Inc updates guidance on survival results from Phase III agenda trial of Genasense in advanced melanoma.
April 22, 2011... Genta Inc updated its formal guidance for release of results from its Phase III, randomised, controlled trial of Genasense (oblimersen sodium) Injection in patients with advanced melanoma, also known as the AGENDA trial. After completion of...

Bio-Rad Laboratories Inc release: published study validates new protein enrichment approach for low-abundance biomarker detection.
April 22, 2011... University of Minnesota researchers found that Bio-Rad Laboratories' ProteoMiner protein enrichment kit enhanced identification of changes to low-abundance proteins and detection of post-translationally modified (PTM) proteins in human saliva....

AstraZeneca PLC's $6 bn stomach ache: Nexium causes bone fractures.
April 22, 2011... AstraZeneca has allegedly known since 2006 that Nexium, its top-selling drug, puts users at an increased risk of bone fractures but failed to warn patients of that until 2010. Millions of people use Nexium, its sister drug Prilosec, or other...

Abbott Japan and Eisai Co Ltd receive approval to market the pancreatic digestive enzyme replacement drug Lipacreon (pancrelipase) in Japan.
April 22, 2011... Abbott Japan Co Ltd (Abbott) and Eisai Co Ltd have announced that they have received approval to market the pancreatic enzyme replacement drug Lipacreon (pancrelipase) in Japan as a pancreatic digestive enzyme replacement in patients with...

Eisai Co Ltd: Halaven receives approval in Japan for the treatment of inoperable and recurrent breast cancer.
April 22, 2011... Eisai Co Ltd has announced that it has received approval to market its novel anticancer Halaven Injection 1 mg (eribulin mesylate) in Japan for the treatment of inoperable and recurrent breast cancer. Discovered and developed by Eisai, Halaven...

Pfizer Inc says patient died in oral RA drug study.
April 22, 2011... Pfizer said four patients enrolled in a trial studying its oral rheumatoid arthritis drug tofacitinib died during or after treatment, but that only one death has been linked to the drug, the WSJ reports. Full results of the study are due to be...

With cancer drug in trials, Mersana Therapeutics Inc gets $6 M.
April 22, 2011... Mersana Therapeutics Inc (Mersana) has raised $6 M of a planned $10 M debt round with private investors, the company reported in a regulatory filing on 21 Apr 2011. The Cambridge company develops medicines using a proprietary, biodegradable...

Bayer affirms the positive benefit-risk profile of its drospirenone-containing oral contraceptives.
April 22, 2011... Bayer HealthCare Pharmaceuticals is aware of two studies published on 22 Apr 2011 in The British Medical Journal. These papers are "Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested...

Notice regarding the effects of the great East Japan earthquake.
April 22, 2011... Kaneka Corp presented information regarding the effects to the Group of this disaster on 14 Mar 2011, under the title of "Notice Regarding the Effects of the 2011 Tohoku-Pacific Ocean Earthquake." The company would now like to present updated...

New drug application approval for GLUBES - Fixed dose combination tablet of a rapid-acting insulin secretagogue and improving agent for postprandial hyperglycemia.
April 22, 2011... On 22 Apr 2011, Kissei Pharmaceutical Co Ltd announced that a New Drug Application for GLUBES, a fixed dose combination tablet of a rapid-acting insulin secretagogue (mitiglinide calcium hydrate, hereinafter "mitiglinide") and an improving agent...

Lundbeck's partner Mochida receives approval of Lexapro in Japan.
April 22, 2011... On 22 Apr 2011, H Lundbeck A/S announced that its partner Mochida Pharmaceutical Co Ltd (Mochida) has obtained approval of Lexapro 10mg (escitalopram) from the Japanese Ministry of Health, Labour and Welfare (MHLW). Lundbeck has partnered with...

Implantation or injectable dosage form new animal drugs; enrofloxacin.
April 22, 2011... The US Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Bayer HealthCare LLC. The supplement to NADA 141-068 for Baytril 100...

Hindustan Zinc targets 500 tonne silver output in 2100-2012: 4Q 2010-2011 net profit rises 43% on higher output, better realisations.(Financial report)
April 22, 2011... Hindustan Zinc, belonging to Vedanta Group, has posted 43% higher net profit at Rup 1771 crores on revenues of Rup 3197 crores for 4Q ended Mar 2011 (net profit of Rup 1239 crores on revenues of Rup 2498 crores in 4Q ended Mar 2010). The company...

Triflusulfuron-methyl; pesticide tolerances.
April 22, 2011... This regulation, issued by the US Environmental Protection Agency (EPA), establishes tolerances for residues of triflusulfuron-methyl in or on beet, garden, roots at 0.01 ppm; and beet, garden, tops at 0.02 ppm. Interregional Research Project...

Biocon to invest Rup 450 crores on insulin programmes.
April 22, 2011... Pharma firm Biocon proposes to invest Rup 450 crores on insulin programmes by 2014/2015 besides Rup 100 crores on a dedicated research and development facility with 600 scientists in Bangalore, India. Apart from this, the company will invest Rup...

Niyamgiri mining: Apex Court issues notice to Sterlite, Orissa Government, Environment Ministry.
April 22, 2011... The honourable Supreme Court of India issued clarification notice to the Ministry of Environment and Forests (MoEF), Sterlite Industries, and the state Government of Orissa on the plea of Orissa Mining Corp (OMC) challenging the cancellation of...

Certain polyester staple fibre from Taiwan: preliminary results of antidumping duty administrative review.
April 21, 2011... The US Department of Commerce is conducting an administrative review of the antidumping duty order on certain polyester staple fibre (PSF) from Taiwan. The period of review is 1 May 2009 through 30 Apr 2010. This review covers imports of certain...

Importer of controlled substances; notice of registration (Chattem Chemicals Inc).
April 21, 2011... Chattem Chemicals Inc, 3801 St Elmo Avenue, Building 18, Chattanooga, TN, USA, made application by letter to the US Drug Enforcement Administration (DEA) on 19 Nov 2010 to be registered as an importer of 4-anilino-N-phenethyl-4-piperidine, a...

Indosolar, China GCL to help develop solar farms in India.
April 21, 2011... To facilitate the development of solar farms in India, China's GCL Solar System Ltd (GCL) and Indosolar Ltd have signed a memorandum of understanding. The scope of the cooperation includes partnering in marketing efforts, business generation in...

Oral pill trial to halt HIV in women is stopped.
April 21, 2011... A trial of an oral pill aimed at preventing HIV infection in African women has been halted due to poor results, the trial operator Family Health International announced this week. The US Centers for Disease Control described the results as...

Apollo Tyres expects Europe after-market sales to rise: Hopes to make mark with winter bookings.
April 21, 2011... Apollo Tyres plans to increase the after-market sales of its branded tyres to 60,000-65,000/month in the ensuing winter season. At present the company sells about 50,000 units/month of its branded tyres in Germany, Netherlands, Italy and the UK....

Lupin gets US regulator nod for diabetes drug.
April 21, 2011... The United States Food and Drug Administration has granted tentative approval to the Lupin Pharmaceuticals Ind, the US arm of pharma firm Lupin, for the company's generic metformin hydrochloride extended-release tablets in 500 mg and 1000mg...

BP commits to early restoration projects along Gulf Coast.
April 21, 2011... On 21 Apr 2011, BP Exploration & Production Inc (BP) announced it has signed a ground breaking agreement with federal and state agencies that will accelerate work starting this year to restore areas of the Gulf of Mexico that were affected...

Notice of change of interests in Riversdale.
April 21, 2011... On 21 Apr 2011, Rio Tinto announced its relevant interest in Riversdale Mining Ltd increased from 128,577,752 ordinary shares (52.60%), as disclosed in its most recent substantial holding notice relating to Riversdale dated 11 Apr 2011, to...

New and generic drug approvals: Votrient Oral Tablet, GSK.
April 21, 2011... On 21 Apr 2011, the US Food and Drug Administration announced approval of NDA 022465 (control supplement) for Votrient Oral Tablet. The product contains pazopanib hydrochloride at 200mg or 400mg (eq base), is manufactured by GSK, and is...

New and generic drug approvals: Divalproex Sodium Delayed Release Oral Tablet, Aurobindo Pharma.
April 21, 2011... On 21 Apr 2011, the US Food and Drug Administration announced approval of ANDA 090554 for Divalproex Sodium Delayed Release Oral Tablet. The product contains divalproex sodium at 125mg, 250mg, or 500mg, is manufactured by Aurobindo Pharma, and...

Commission communication in the framework of the implementation of Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products.
April 21, 2011... The European Commission has communicated in the framework of the implementation of Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products. A table depicting Reference and title of the harmonised standard...

Commission Implementing Directive 2011/52/EU of 20 Apr 2011 amending Council Directive 91/414/EEC to include carboxin as active substance and amending Commission Decision 2008/934/EC.
April 21, 2011... Adopted on 20 Apr 2011. The European Commission, having regard to the Treaty on the Functioning of the European Union, having regard to Council Directive 91/414/EEC of 15 Jul 1991 concerning the placing of plant protection products on the market...

Commission Implementing Directive 2011/53/EU of 20 Apr 2011 amending Council Directive 91/414/EEC to include dazomet as active substance and amending Commission Decision 2008/934/EC.
April 21, 2011... Adopted on 20 Apr 2011. The European Commission, having regard to the Treaty on the Functioning of the European Union, having regard to Council Directive 91/414/EEC of 15 Jul 1991 concerning the placing of plant protection products on the...

Commission Implementing Directive 2011/54/EU of 20 Apr 2011 amending Council Directive 91/414/EEC to include metaldehyde as active substance and amending Commission Decision 2008/934/EC.
April 21, 2011... Adopted on 20 Apr 2011. The European Commission, having regard to the Treaty on the Functioning of the European Union, having regard to Council Directive 91/414/EEC of 15 Jul 1991 concerning the placing of plant protection products on the...

Flint Group announces further price increases for packaging and narrow web inks in N America.
April 21, 2011... In light of the repetitive and continuing raw material cost increases since Jan 2011, it is necessary for the Flint Group to increase the price of inks and coatings in N America. Water and solvent based products will increase 8% (with the...

UCB and Amgen announce positive phase 2 results of CDP7851/AMG785 in patients with post menopausal osteoporosis (PMO).(Financial report)(Clinical report)
April 21, 2011... On 21 Apr 2011 UCB and Amgen announced positive top-line results from their Phase 2 clinical study comparing sclerostin-antibody CDP7851/AMG785 to placebo in post-menopausal women with low bone mineral density (BMD) for the treatment of...

Brazil's Petrobras to cut natural gas prices by 9.7% in May 2011.
April 21, 2011... Brazilian petrochemical giant Petrobras announced 9.7% reduction in price of Brazil-produced natural gas effective from 01 May 2011. Petrobras divulged that the price cut was necessitated owing to increase in energy prices and their adverse...

AiCuris receives orphan drug designation for its innovative Phase II drug AIC246 for the prevention of HCMV disease.
April 21, 2011... AiCuris announced that AIC246, the company's inhibitor against the human cytomegalovirus HCMV, currently undergoing Phase IIb testing, has been granted Orphan Drug designation for the prevention of HCMV disease. This decision was made by the...

Dynavax Technologies Corp initiates first human trial in lupus programme.
April 21, 2011... Dynavax Technologies Corp announced the start of dosing in the first human clinical trial in its lupus programme. Initiation of this trial entitles Dynavax to receive a $6 M milestone payment from GlaxoSmithKline (GSK), its partner in a...

ICON and ACRONET Corp sign alliance agreement in Japan.
April 21, 2011... ICON plc and ACRONET Corp have signed an alliance agreement. Through the agreement, ICON and ACRONET will collaborate to offer global and Japanese pharmaceutical clients a full range of clinical development capabilities to manage trials on a...

Celsion Corp announces issuance of Japanese patent covering ThermoDox technologies.
April 21, 2011... Celsion Corp has announced that the Japan Patent Office has granted the Japanese counterpart of the 'Needham' composition of matter patent, 'Temperature-Sensitive Liposomal Formulation,' which is issued in various regions around the world,...

Innovotech Inc's MBEC assay approved as international biofilm standard.
April 21, 2011... Innovotech Inc has announced that its MBEC Assay has been approved as an ASTM International (ASTM) standard. The Assay was validated for testing the effectiveness of hard surface disinfectants formulated to kill biofilm. The MBEC Assay is a...

mPhase Technologies Inc developing battery for G-Force activated application.
April 21, 2011... mPhase Technologies Inc (mPhase) has announced that it is engaged in the preliminary discussions with a major prime contractor of military applications to potentially adapt its battery technology and reserve battery 'know-how' to serve as a...

GEA Pharma Systems release: in-line control of high shear granulation.
April 21, 2011... Genzyme was looking for a PAT solution to control the high shear granulation of a development product by measuring a critical product attribute, rather than relying purely on time based processing or impeller current loading. The company used an...

Pfizer comments on Oral Sync tofacitinib data in EULAR Abstract LB0005.
April 21, 2011... Pfizer Inc commented on an abstract concerning the Oral Sync Phase III study of tofacitinib in patients with rheumatoid arthritis (RA) which has been posted for the European League Against Rheumatism (EULAR) conference. In this study, four...

US Congressman Rush Holt visits VaxInnate; lauds Government funding for development of modern flu vaccines.
April 21, 2011... US Congressman Rush Holt (R-12th) visited the headquarters of VaxInnate Corp, where he congratulated the biotechnology company on having received a US Government contract to fund development of the next generation of flu vaccines and called for...

Spectrum Pharmaceuticals announces FDA approval of Fusilev's Ready-To-Use formulation (RTU).
April 21, 2011... Spectrum Pharmaceuticals (Spectrum) announced that the US Food and Drug Administration (FDA) has approved the company's Supplemental New Drug Application for Fusilev (levoleucovorin) Injection. Unlike the currently available lyophilised product,...

Research and Markets: Ophthalmology Drug Futures.
April 21, 2011... Research and Markets has announced the addition of the 'Ophthalmology Drug Futures' report to their offering. A complete and practical analysis of Ophthalmology Drugs packed with facts, figures and forecasts for launched and late-stage products....

The majority of surveyed US neurologists selected Tysabri as the most effective therapy for the treatment of relapsing-remitting multiple sclerosis, when compared to other currently available agents.(Clinical report)
April 21, 2011... Decision Resources finds that the majority of surveyed US neurologists (63%) selected Biogen Idec/Elan's Tysabri as the most effective therapy for the treatment of relapsing-remitting multiple sclerosis, when compared to other currently...

Oragenics receives US patent for ProBiora3.
April 21, 2011... Florida-based biopharmaceutical company Oragenics Inc announced the issuance of patent number 7931892 from the US Patent and Trademark office for ProBiora3, a proprietary blend of naturally occurring oral bacteria shown to produce a wide range...

Merck and Sanofi Pasteur initiate Phase III study in the US of paediatric combination vaccine to help prevent six infectious diseases.
April 21, 2011... Merck (known outside the US and Canada as MSD) and Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced the initiation of a Phase III clinical programme to evaluate the safety and immunogenicity of an investigational...

Costar Midstream LLC, and Energy Spectrum Partners VI team up to develop midstream infrastructure opportunities in the southwest.
April 21, 2011... Costar Midstream LLC (Costar) and Energy Spectrum Partners VI (ESP VI) have come together to acquire certain natural gas processing assets in the Granite Wash area of the Texas and Oklahoma Panhandle. Costar's objective is to build a sizable...

SolarWorld solar panels power net-zero homes in Hawaiian home land's pilot community project.
April 21, 2011... SolarWorld's high performance solar panels are powering an advance in sustainable home development in the heart of Hawaii: They are generating electric power atop 19 homes and a community centre for low-income residents of indigenous backgrounds...

Kuraray announces concerning the commercialisation of concentrating lens for solar power generation.
April 21, 2011... Kuraray Co Ltd announced the commercialisation of a concentrating lens and supplied them to Amonix Inc. Under the slogan, 'Creation and Expansion of New Businesses,' Kuraray has engaged in the GS-Twins three-year medium-term action plan since...

Evergreen Solar String Ribbon solar panels certified for ammonia gas resistance testing by TUV Rheinland.
April 21, 2011... Evergreen Solar Inc announced its ES-A and ES-E series solar panels are some of the first panels to be certified for ammonia gas resistance by TUV Rheinland. This ammonia gas resistance certification extends the ability of Evergreen Solar panels...

Research and Markets: Czech Republic Oil and Gas Report 1Q 2011 - gas demand growth is relatively high.(Report)
April 21, 2011... Research and Markets has announced the addition of the 'Czech Republic Oil and Gas Report 1Q 2011' report to their offering. This latest Czech Republic Oil & Gas Report from BMI forecasts that the country will account for 3.36% of Central...

Dow announces plans to fully integrate and grow North American performance businesses with shale gas liquids.
April 21, 2011... The Dow Chemical company announced comprehensive plans to increase the company's ethylene and propylene production and to integrate its US operations into feedstock opportunities available from increasing supplies of US shale gas in the...

15 additional contracts signed with solar photovoltaic industry leaders.
April 21, 2011... New installations of solar photovoltaic panels reached 17GWp in 2010, doubling the amount installed the previous year. Leading solar panel manufacturers around the world and in Asia in particular, are therefore continuing to add significant new...

Start of precursor production for BMW project.
April 21, 2011... MRC-SGL Precursor Co Ltd (hereinafter MSP), a joint corporation between Mitsubishi Rayon Co Ltd (hereinafter MRC) and SGL Group, The Carbon Co, (hereinafter SGL) successfully started commercial production of PAN based precursor (Precursor), a...

Announcement regarding recall of OTC eye drop product.
April 21, 2011... On 21 Apr 2011, Santen Pharmaceutical Co Ltd announced the recall of one production lot (please see below for details) of its Sante Xyon eye drops which were sold only in Japan. Santen identified a possibility that a small number of Sante Xyon...

Manufacturer of controlled substances; notice of registration (Lin Zhi International Inc).
April 20, 2011... Lin Zhi International Inc, 670 Almanor Avenue, Sunnyvale, CA, USA, made application by renewal to the US Drug Enforcement Administration (DEA) on 17 Jun 2010 to be registered as a bulk manufacturer of the basic classes of controlled substances...

Fluopicolide; pesticide tolerances.
April 20, 2011... This regulation, issued by the US Environmental Protection Agency (EPA), establishes tolerances for residues of the fungicide, fluopicolide, in or on vegetable, tuberous and corm subgroup 1C at 0.02 ppm; potato, processed potato waste at 0.05...

Manufacturer of controlled substances; notice of application (Noramco Inc).
April 20, 2011... Noramco Inc, 500 Swedes Landing Road, Wilmington, DE, USA, made application by letter to the US Drug Enforcement Administration (DEA) on 3 Nov 2010 as a bulk manufacturer of the basic classes of controlled substances in schedule II, namely...

Manufacturer of controlled substances; notice of application (Stepan Co).
April 20, 2011... Stepan Co, Natural Products Department, 100 W Hunter Avenue, Maywood, NJ, USA, made application by renewal to the US Drug Enforcement Administration (DEA) on 24 Feb 2011 as a bulk manufacturer of the basic classes of controlled substances in...

Manufacturer of controlled substances; notice of registration (Chattem Chemicals Inc).
April 20, 2011... Chattem Chemicals Inc, 3801 St Elmo Avenue, Building 18, Chattanooga, TN, USA, made application by renewal to the US Drug Enforcement Administration (DEA) on 2 Aug 2010 to be registered as a bulk manufacturer of the basic classes of 24...

Procedures relating to the implementation of the common commercial policy European Commission - Notice of the impending expiry of certain anti-dumping measures.
April 20, 2011... As provided for in Article 11(2) of Council Regulation (EC) No 1225/2009 of 30 Nov 2009 on protection against dumped imports from countries not members of the European Community (1), the European Commission gives notice that, unless a review is...